| scholarly article | Q13442814 |
| P50 | author | Annie E Wentz | Q81644728 |
| Elizabeth M. Brunt | Q110296299 | ||
| Peter A Crawford | Q57274480 | ||
| P2093 | author name string | Jason M Doherty | |
| Joel R Garbow | |||
| David G Cotter | |||
| Mary L Weber | |||
| Rebecca C Schugar | |||
| Sarah Travers | |||
| Nkiruka Ezenwajiaku | |||
| P2860 | cites work | The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies | Q24646616 |
| FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response | Q24653481 | ||
| Mechanisms underlying the resistance to diet-induced obesity in germ-free mice | Q24676006 | ||
| CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription | Q28287446 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes | Q28575190 | ||
| Regulation of glucose homeostasis through a XBP-1-FoxO1 interaction | Q28592129 | ||
| Prevalence and trends in obesity among US adults, 1999-2008 | Q29547759 | ||
| Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states | Q29615208 | ||
| The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance | Q29616026 | ||
| In vivo MRS measurement of liver lipid levels in mice | Q30924323 | ||
| PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism | Q33283063 | ||
| Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet | Q33352617 | ||
| PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis | Q33564184 | ||
| Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice | Q33634147 | ||
| Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. | Q33896647 | ||
| Microbial regulation of intestinal radiosensitivity | Q33930212 | ||
| Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis | Q34019712 | ||
| Adaptation of myocardial substrate metabolism to a ketogenic nutrient environment | Q34042546 | ||
| Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial | Q34175095 | ||
| A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain | Q34305197 | ||
| Autophagy: assays and artifacts | Q34341096 | ||
| A high-fat, ketogenic diet induces a unique metabolic state in mice | Q79771171 | ||
| Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis | Q81441036 | ||
| A life-threatening complication of Atkins diet | Q82875260 | ||
| Pathology of nonalcoholic fatty liver disease | Q83094715 | ||
| Linking the inflammasome to obesity-related disease | Q83379079 | ||
| Fibroblast growth factor 21 as a biomarker for NAFLD: Integrating pathobiology into clinical practice | Q84962979 | ||
| Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death | Q34564595 | ||
| Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial | Q34577036 | ||
| Low-carbohydrate nutrition and metabolism. | Q34660572 | ||
| Postnatal lymphatic partitioning from the blood vasculature in the small intestine requires fasting-induced adipose factor | Q35568473 | ||
| The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism | Q35652475 | ||
| Fuel metabolism in starvation | Q36539491 | ||
| Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications | Q36617551 | ||
| Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease | Q36889026 | ||
| Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. | Q36983521 | ||
| Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis. | Q37044201 | ||
| Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation | Q37237047 | ||
| Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet | Q37297977 | ||
| Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity | Q37340863 | ||
| Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids | Q37367423 | ||
| A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss | Q37430803 | ||
| As a matter of fat. | Q37543677 | ||
| Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites | Q37777696 | ||
| Metabolic management of brain cancer | Q37784054 | ||
| Endoplasmic Reticulum Stress and Inflammation in Obesity and Diabetes | Q37784942 | ||
| Ketosis and the Ketogenic Diet, 2010: Advances in Treating Epilepsy and Other Disorders | Q37807788 | ||
| Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. | Q38309701 | ||
| Leptin contributes to slower weight gain in juvenile rodents on a ketogenic diet | Q38310230 | ||
| PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. | Q38332175 | ||
| PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis | Q39753643 | ||
| Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes | Q40038212 | ||
| UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. | Q42041480 | ||
| Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study | Q42165604 | ||
| Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice | Q43224118 | ||
| Pioglitazone reduces ER stress in the liver: direct monitoring of in vivo ER stress using ER stress-activated indicator transgenic mice. | Q43269505 | ||
| Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. | Q44477314 | ||
| Involvement of endoplasmic reticulum stress in insulin resistance and diabetes | Q45127777 | ||
| Words of wisdom. Re: Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, | Q47577057 | ||
| The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. | Q48691421 | ||
| A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. | Q54028807 | ||
| Cardiac complications in pediatric patients on the ketogenic diet. | Q54045642 | ||
| The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study. | Q55042936 | ||
| Induction of ketosis in rats fed low-carbohydrate, high-fat diets depends on the relative abundance of dietary fat and protein | Q56964468 | ||
| Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin | Q73555615 | ||
| P433 | issue | 6 | |
| P921 | main subject | steatosis | Q1365091 |
| P304 | page(s) | G956-67 | |
| P577 | publication date | 2011-03-31 | |
| P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
| P1476 | title | Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet | |
| P478 | volume | 300 |
| Q37417076 | A low-carbohydrate high-fat diet decreases lean mass and impairs cardiac function in pair-fed female C57BL/6J mice |
| Q27310129 | A low-carbohydrate high-fat diet increases weight gain and does not improve glucose tolerance, insulin secretion or β-cell mass in NZO mice |
| Q91793965 | A low-carbohydrate ketogenic diet induces the expression of very-low-density lipoprotein receptor in liver and affects its associated metabolic abnormalities |
| Q64269249 | A low-carbohydrate ketogenic diet promotes ganglioside synthesis via the transcriptional regulation of ganglioside metabolism-related genes |
| Q30411774 | A small amount of dietary carbohydrate can promote the HFD-induced insulin resistance to a maximal level |
| Q36424947 | A very low carbohydrate ketogenic diet prevents the progression of hepatic steatosis caused by hyperglycemia in a juvenile obese mouse model |
| Q36889022 | Adaptive changes in amino acid metabolism permit normal longevity in mice consuming a low-carbohydrate ketogenic diet |
| Q90266551 | Altered nutrient status reprograms host inflammation and metabolic health via gut microbiota |
| Q55497656 | An 8-Week Ketogenic Low Carbohydrate, High Fat Diet Enhanced Exhaustive Exercise Capacity in Mice. |
| Q97519525 | Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease |
| Q89633578 | Anti-aging Effects of Calorie Restriction (CR) and CR Mimetics based on the Senoinflammation Concept |
| Q24658455 | Apoptosis induced by a low-carbohydrate and high-protein diet in rat livers |
| Q90616580 | Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature |
| Q41069330 | Beta-adrenergic receptors are critical for weight loss but not for other metabolic adaptations to the consumption of a ketogenic diet in male mice |
| Q41965207 | CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPARα. |
| Q26991952 | Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction |
| Q93015677 | Diet Composition for the Management of Obesity and Obesity-related Disorders |
| Q30301218 | Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine |
| Q30277250 | Dietary sugar intake increases liver tumor incidence in female mice |
| Q33749608 | Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies. |
| Q51673321 | Effects of a ketogenic diet on adipose tissue, liver, and serum biomarkers in sedentary rats and rats that exercised via resisted voluntary wheel running. |
| Q40697795 | Eucaloric Ketogenic Diet Reduces Hypoglycemia and Inflammation in Mice with Endotoxemia |
| Q91851202 | Glucose and Lipid Homeostasis and Inflammation in Humans Following an Isocaloric Ketogenic Diet |
| Q82798287 | Hepatic endoplasmic reticulum stress in obesity: deeper insights into processes, but are they relevant to nonalcoholic steatohepatitis? |
| Q36901925 | Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes. |
| Q47687187 | Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets |
| Q24564130 | Integrated physiology and systems biology of PPARα |
| Q64252736 | Keto-Adaptation and Endurance Exercise Capacity, Fatigue Recovery, and Exercise-Induced Muscle and Organ Damage Prevention: A Narrative Review |
| Q97643502 | Ketogenesis activates metabolically protective γδ T cells in visceral adipose tissue |
| Q35606508 | Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue |
| Q90334375 | Ketogenic Diets and Exercise Performance |
| Q40244875 | Ketogenic diet attenuates hepatopathy in mouse model of respiratory chain complex III deficiency caused by a Bcs1l mutation |
| Q34252732 | Ketone bodies as signaling metabolites. |
| Q47190341 | Long-term ketogenic diet causes glucose intolerance and reduced β- and α-cell mass but no weight loss in mice |
| Q34109997 | Long-term low carbohydrate diet leads to deleterious metabolic manifestations in diabetic mice |
| Q27007233 | Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease |
| Q42367244 | Meta-fibrosis links positive energy balance and mitochondrial metabolism to insulin resistance |
| Q42619261 | Methionine and choline regulate the metabolic phenotype of a ketogenic diet |
| Q34185231 | Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse |
| Q28071265 | Molecular Pathogenesis of NASH |
| Q39126658 | Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics |
| Q33747445 | Muscle PGC-1α is required for long-term systemic and local adaptations to a ketogenic diet in mice |
| Q35931190 | NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. |
| Q92487786 | Nutrition and exercise in Pompe disease |
| Q54961877 | Nutritional Ketosis and Mitohormesis: Potential Implications for Mitochondrial Function and Human Health. |
| Q90233479 | Reduced caloric intake and periodic fasting independently contribute to metabolic effects of caloric restriction |
| Q92473034 | Response of Liver Metabolic Pathways to Ketogenic Diet and Exercise Are Not Additive |
| Q36818384 | Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease |
| Q34979884 | Role of choline deficiency in the Fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet |
| Q38120308 | Selectively starving cancer cells through dietary manipulation: methods and clinical implications |
| Q58794806 | Short-term feeding of a ketogenic diet induces more severe hepatic insulin resistance than an obesogenic high-fat diet |
| Q36593104 | Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation |
| Q93164481 | The Therapeutic Potential of Ketogenic Diet Throughout Life: Focus on Metabolic, Neurodevelopmental and Neurodegenerative Disorders |
| Q35852049 | The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy |
| Q34761132 | Toll-like receptor 4 knockout mice are protected against endoplasmic reticulum stress induced by a high-fat diet |
| Q47154314 | Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease |
| Q42733357 | Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression |
| Q91807467 | Very low-carbohydrate, high-fat, weight reduction diet decreases hepatic gene response to glucose in obese rats |
| Q35553084 | β-hydroxybutyrate: much more than a metabolite |
Search more.